Login / Signup

Neutralizing Antibodies against SARS-CoV-2 Beta and Omicron Variants Inhibition Comparison after BNT162b2 mRNA Booster Doses with a New PETIA sVNT Assay.

Marta FogolariBruno Daniele LeoniMarina De CesarisRita ItalianoFlavio DaviniGinevra Azzurra MiccoliDaniele DonatiLuigi ClericoAndrea StanzialeGiovanni SaviniNicola PetrosilloMassimo CiccozziLorenzo SommellaElisabetta RivaPaolo FaziiSilvia Angeletti
Published in: Diagnostics (Basel, Switzerland) (2023)
This study correlates vaccine-induced IgG expression and neutralizing activity using a new PETIA assay, suggesting its usefulness for SARS-CoV2 infection management.
Keyphrases
  • sars cov
  • high throughput
  • respiratory syndrome coronavirus
  • dengue virus
  • poor prognosis
  • binding protein
  • diabetic rats
  • copy number
  • drug induced
  • oxidative stress
  • coronavirus disease
  • genome wide
  • clinical evaluation